1) How is Sanofi using innovative healthcare biotechnologies to improve treatments for cancer patients?
We are building on a rich legacy in oncology. Our strong pipeline today reflects our renewed commitment to developing new therapies that could both change outcomes and have a positive impact on the lives and wellbeing of people living with many different types of cancer. We are building a new generation of medicines designed to either attack and destroy cancer cells directly or mobilize the immune system to mount a strong defense against cancer. We have been reinforcing our foundations in disease biology with a diverse toolbox of advanced technologies for designing new types of medicines, and with strategic collaborations that help us advance the science more quickly. Because the more “weapons” for attacking cancer we stock in our armory, the more opportunities our scientists have for discovering therapies that will help patients.